Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study.

Dragani M, Ansuinelli M, Papayannidis C, Fracchiolla N, Cardinali V, Cedrone M, Guolo F, Perrone S, Salutari P, Todisco E, Foà R, Chiaretti S

Open source

DOI
10.3324/haematol.2024.286325
Published
2025 May 1
Container
Haematologica
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2024.286325,
  title = {Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study.},
  author = {Dragani M and Ansuinelli M and Papayannidis C and Fracchiolla N and Cardinali V and Cedrone M and Guolo F and Perrone S and Salutari P and Todisco E and Foà R and Chiaretti S},
  year = {2025},
  journal = {Haematologica},
  doi = {10.3324/haematol.2024.286325},
  url = {https://doi.org/10.3324/haematol.2024.286325}
}

RIS

TY  - JOUR
TI  - Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study.
AU  - Dragani M
AU  - Ansuinelli M
AU  - Papayannidis C
AU  - Fracchiolla N
AU  - Cardinali V
AU  - Cedrone M
AU  - Guolo F
AU  - Perrone S
AU  - Salutari P
AU  - Todisco E
AU  - Foà R
AU  - Chiaretti S
PY  - 2025
JO  - Haematologica
DO  - 10.3324/haematol.2024.286325
UR  - https://doi.org/10.3324/haematol.2024.286325
ER  - 

APA

M, D., M, A., C, P., N, F., V, C., M, C., F, G., S, P., P, S., E, T., R, F., & S, C. (2025). Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study.. Haematologica. https://doi.org/10.3324/haematol.2024.286325

Source records